Back to VP VANGUARD PORTFOLIO MANAGEMENT LLC
FDMT2 quarters
Position history for VPVANGUARD PORTFOLIO MANAGEMENT LLC's holdings in 4D MOLECULAR THERAPEUTICS IN
VANGUARD PORTFOLIO MANAGEMENT LLC holds 579,903 shares of FDMT (4D MOLECULAR THERAPEUTICS IN), worth $7.7M as of 2026-Q2. The position was increased (+4.3% shares). FDMT represents 0.0% of VANGUARD PORTFOLIO MANAGEMENT LLC's portfolio.
Current Value
$7.7M
Current Shares
579,903
Total Value Change
+$2.5M
Total Shares Change
+24,074
Quarter-by-Quarter History
Other major holders of FDMT: VIKING GLOBAL INVESTORS LP, RA CAPITAL MANAGEMENT, L.P., BlackRock Finance, Inc.